Skip to main content
Uncategorized

International Symposium on Receptors of the Immune System

By 7 de June de 2004November 18th, 2020No Comments
< Back to news
Inauguration
 07.06.2004

International Symposium on Receptors of the Immune System

Scientists from several fields linked to immunology will participate in the "" to be held in the Auditorium at the Parc Científic de Barcelona (PCB, Barcelona Science Park) on 10 and 11 June. This symposium will present recent studies and research tendencies in immunology, with particular emphasis on receptors of the immune system. These are key elements in the discovery of new vaccines and the design of new drugs for diseases such as AIDS or smallpox, among others.


The symposium has been coordinated by Antonio Celada, senior professor at the Universitat de Barcelona (UB) and researcher in the Macrophage Biology Group, which addresses “Regulation of Gene Expression”, at the Institute of Biomedical Research (IRBB-PCB) and by Francisco Lozano, professor of immunology at the UB. The symposium is supported by the PCB and the Fundación Ramon Areces. During the congress, researchers working in this field of biomedicine and also biochemists, molecular biologists, pharmacists, clinicians and physiologists, will discuss the developments made in recent years on the receptors of the cells of the immune system that play a crucial role in immune response.

Immunology is not only a theoretical science but also has applied aspects. In addition, this discipline is strongly linked to clinical medicine, in which it is a key instrument in fields such as transplants, immunodeficiency or autoimmune diseases. In recent years, the introduction of new technologies used in cell biology, biochemistry, and above all molecular biology, have transformed immunology into an essentially experimental science. Furthermore, thanks to advances in knowledge on the genome, many receptors have been described in cells in bone marrow and in the lymphatic system. These receptors may be crucial for the design of drugs for therapeutic application in diseases such as AIDS. These findings open up new avenues and perspectives in research on the immune system.